Experimental rationale for treatment of high-risk human melanoma with zinc chloride fixative paste: Increased resistance to tumor challenge in murine melanoma model

Dermatologic Surgery

Volumn 24, Issue 9, 1998, Pages 1021-1025

  Kalish, Richard S ^a,b,e   Wood, Jonathan A ^a   Siegel, Daniel M ^a   Kaye, Valda N ^c   Brooks, Norman A ^d  

^a STONY BROOK UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIXATIVE; ZINC CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CELL INFILTRATION; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; HOST RESISTANCE; MELANOMA; MOUSE; NONHUMAN; PASTE; PRIORITY JOURNAL; SKIN SURGERY; TISSUE FIXATION; TOPICAL DRUG ADMINISTRATION;

EID: 0031710133     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1998.tb04296.x     Document Type: Article

References (22)

1. Kirkwood JM, Strawderman MH, Ernstoff MS, et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol 1996;14:7-17.
2. Mohs FE. Chemosurgery for melanoma. Arch Dermatol 1977;133: 285-91.
3. Clark WH, From L, Bernardo EA, Mihm MC. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 1969;29:705-27.
4. Brooks NA. Fixed-tissue micrographic surgery in the treatment of cutaneous melanoma: an overlooked cancer treatment strategy [editorial]. J Dermatol Surg Oncol 1992;18:999-1000.
5. Zitelli JA, Mohs FE, Larson P, Snow S. Mohs micrographic surgery for melanoma. Dermatol Clin 1989;7:833-43.
6. Kripke ML. Speculations on the role of ultraviolet radiation in the development of malignant melanoma. J Natl Cancer Inst 1979;63: 541.
7. Mohs FE, Guyer MF. Pre-excisional fixation of tissues in the treatment of cancer in rats. Cancer Res 1941;1:49-51.
8. Mohs FE. Chemosurgery Microscopically Controlled Surgery for Skin Cancer. Springfield, IL: Charles C. Thomas, 1978:3-29, 225-48.
9. Adler A, Oraz R, Bystryn JC. In vitro cell-mediated immune responses induced by a polyvalent allogeneic melanoma vaccine. Cancer Biotherapy 1995;10:211-24.
10. Wallack MK, Sivanandham M, Whooley B, Ditaranto K, Bartolucci AA. Favorable clinical responses in subsets of patients from a randomized, multi-institutional melanoma vaccine trial. Annals Surg Oncol 1996;3:110-7.
11. Schultz N, Oratz R, Chen D, et al. Effect of DETOX as an adjuvant for melanoma vaccine. Vaccine 1995;13:503-8.
12. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 1996;183:283-7.
13. Townsend SE, Allison JP. Tumor rejection after costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 1993;259: 368-70.
14. Fujii H, Inobe M, Kimura F, et al. Vaccination of tumor cells transfected with the B7-1 (CD80) gene induces the anti-metastatic effect and tumor immunity in mice. Int J Cancer 1996;66:219-24.
15. Li Y, McGowan P, Hellstrom I, Hellstrom KE, Chen L. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma. J Immunol 1994;153:421-8.
16. Townsend SE, Su FW, Atherton JM, Allison JP. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res 1994;54:6477-83.
17. Ramakrishna V, Eisenthal A, Skornick Y, Shinitzky M. Increased projection of MHC and tumor antigens in murine B16-BL6 melanoma induced by hydrostatic pressure and chemical crosslinking. Cancer Immunology, Immunotherapy 1993;36:293-9.
18. Nishimura T, Watanabe K, Yahata T, et al. Application of interleukin 12 to antitumor cytokine and gene therapy. Cancer Chemotherapy & Pharmacology. 1996;38(Suppl):27-34.
19. Coughlin CM, Wysocka M, Kurzawa HL, et al. B7-1 and interleukin 12 synergistically induce effective antitumor immunity. Cancer Res 1995;55:4980-7.
20. Arca MJ, Krauss JC, Strome SE, Cameron MJ, Chang AE. Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes. Cancer Immunol Immunother 1996;42:237-45.
21. Zitelli JA, Brown C, Hanusa BH. Mohs micrographic surgery for the treatment of primary cutaneous melanoma. J Am Acad Dermatol 1997;37:236-45.
22. Snow SN, Mohs FE, Oriba HA, Dudley CM, Leverson G, Hetzer M. Cutaneous malignant melanoma treated by Mohs surgery. Dermatol Surg 1997;23:1055-60.